Sinovac Biotech Ltd (SVA) stock
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.47+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.94MP/E –Yield 850.08%
Sinovac Biotech market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Sinovac Biotech's market cap was $464.94M on Nov 11, 2026, against $464.94M a year earlier. Over the last 5 years it ranged from $464.06M to $642.44M, with a median of $464.94M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $464.94M | 0.0% |
| 2025 | Dec 31, 2025 | $464.94M | 0.0% |
| 2024 | Dec 31, 2024 | $464.94M | +0.2% |
| 2023 | Dec 29, 2023 | $464.06M | 0.0% |
| 2022 | Dec 30, 2022 | $464.06M | -27.8% |
| 2021 | Dec 31, 2021 | $642.44M | +0.4% |
| 2020 | Dec 31, 2020 | $639.90M | +39.0% |
| 2019 | Dec 31, 2019 | $460.27M | +15.8% |
| 2018 | Dec 31, 2018 | $397.54M | -11.5% |
| 2017 | Dec 29, 2017 | $449.25M | +33.8% |
| 2016 | Dec 30, 2016 | $335.75M | +5.2% |
| 2015 | Dec 31, 2015 | $319.23M | +9.8% |
| 2014 | Dec 31, 2014 | $290.63M | -13.8% |
| 2013 | Dec 31, 2013 | $337.16M | +96.0% |
| 2012 | Dec 31, 2012 | $171.99M | +44.0% |
| 2011 | Dec 30, 2011 | $119.47M | -38.5% |
| 2010 | Dec 31, 2010 | $194.25M | – |
See a number that looks wrong?